115 related articles for article (PubMed ID: 15351849)
41. Effects of black cohosh on the plasminogen activator system in vascular smooth muscle cells.
Lee DY; Roh CR; Kang YH; Choi D; Lee Y; Rhyu MR; Yoon BK
Maturitas; 2013 Sep; 76(1):75-80. PubMed ID: 23827472
[TBL] [Abstract][Full Text] [Related]
42. Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury.
Barazzone C; Belin D; Piguet PF; Vassalli JD; Sappino AP
J Clin Invest; 1996 Dec; 98(12):2666-73. PubMed ID: 8981909
[TBL] [Abstract][Full Text] [Related]
43. Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro.
Louise CB; Obrig TG
Microvasc Res; 1994 May; 47(3):377-87. PubMed ID: 8084301
[TBL] [Abstract][Full Text] [Related]
44. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
[TBL] [Abstract][Full Text] [Related]
45. Vascular cell-derived fibrinolytic regulators and atherothrombotic vascular disorders (Review).
Shen GX
Int J Mol Med; 1998 Feb; 1(2):399-408. PubMed ID: 9852242
[TBL] [Abstract][Full Text] [Related]
46. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells.
Fukao H; Hagiya Y; Ueshima S; Okada K; Takaishi T; Izaki S; Matsuo O
Thromb Haemost; 1996 Feb; 75(2):352-8. PubMed ID: 8815589
[TBL] [Abstract][Full Text] [Related]
47. On the fibrinolytic system in aged rats, and its reactivity to endotoxin and cytokines.
Emeis JJ; Brouwer A; Barelds RJ; Horan MA; Durham SK; Kooistra T
Thromb Haemost; 1992 Jun; 67(6):697-701. PubMed ID: 1509412
[TBL] [Abstract][Full Text] [Related]
48. Plasminogen activator inhibitor type 1 inhibits smooth muscle cell proliferation in pulmonary arterial hypertension.
Kouri FM; Queisser MA; Königshoff M; Chrobak I; Preissner KT; Seeger W; Eickelberg O
Int J Biochem Cell Biol; 2008; 40(9):1872-82. PubMed ID: 18337154
[TBL] [Abstract][Full Text] [Related]
49. Changes in coagulation-fibrinolysis balance in blood mononuclear cells and in gastric mucosa from patients with Helicobacter pylori infection.
Colucci M; Rossiello MR; Pentimone A; Berloco P; Russo F; Di Leo A; Semeraro N
Thromb Res; 2005; 116(6):471-7. PubMed ID: 16181982
[TBL] [Abstract][Full Text] [Related]
50. HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins.
Wiesbauer F; Kaun C; Zorn G; Maurer G; Huber K; Wojta J
Br J Pharmacol; 2002 Jan; 135(1):284-92. PubMed ID: 11786505
[TBL] [Abstract][Full Text] [Related]
51. Enhancement of tissue plasminogen activator-induced fibrinolysis by activated protein C in endotoxin-treated rabbits.
Krishnamurti C; Young GD; Barr CF; Colleton CA; Alving BM
J Lab Clin Med; 1991 Dec; 118(6):523-30. PubMed ID: 1744501
[TBL] [Abstract][Full Text] [Related]
52. [The regulation of blood coagulation and fibrinolysis by vascular endothelial cells].
Nishimura H; Tsuji H; Yoshizumi M; Nakagawa M
Nihon Rinsho; 1999 Jul; 57(7):1492-6. PubMed ID: 10429446
[TBL] [Abstract][Full Text] [Related]
53. [Effects of andrographolide on the expression of procoagulant and fibrinolytic inhibition factors in rat type II alveolar epithelial cells stimulated by lipopolysaccharide].
Yang G; Li X; Shen F; Zheng X; He T; Li S; Cheng Y; Li Q; Li W; Qin J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):155-160. PubMed ID: 33729132
[TBL] [Abstract][Full Text] [Related]
54. Sepsis-induced coagulation in the baboon lung is associated with decreased tissue factor pathway inhibitor.
Tang H; Ivanciu L; Popescu N; Peer G; Hack E; Lupu C; Taylor FB; Lupu F
Am J Pathol; 2007 Sep; 171(3):1066-77. PubMed ID: 17640967
[TBL] [Abstract][Full Text] [Related]
55. IKKβ regulates the expression of coagulation and fibrinolysis factors through the NF-κB canonical pathway in LPS-stimulated alveolar epithelial cells type II.
Liu B; Wang Y; Wu Y; Cheng Y; Qian H; Yang H; Shen F
Exp Ther Med; 2019 Oct; 18(4):2859-2866. PubMed ID: 31572531
[TBL] [Abstract][Full Text] [Related]
56. Upregulation of fibrinolysis by adenovirus-mediated transfer of urokinase-type plasminogen activator genes to lung cells in vitro and in vivo.
Hattori N; Sisson TH; Xu Y; Simon RH
Hum Gene Ther; 1999 Jan; 10(2):215-22. PubMed ID: 10022546
[TBL] [Abstract][Full Text] [Related]
57. Role of enzymes mediating thrombosis and thrombolysis in lung disease.
Chapman HA; Bertozzi P; Reilly JJ
Chest; 1988 Jun; 93(6):1256-63. PubMed ID: 3131071
[TBL] [Abstract][Full Text] [Related]
58. Fibrinolysis in LPS-induced chronic airway disease.
Savov JD; Brass DM; Berman KG; McElvania E; Schwartz DA
Am J Physiol Lung Cell Mol Physiol; 2003 Oct; 285(4):L940-8. PubMed ID: 12818888
[TBL] [Abstract][Full Text] [Related]
59. Plasmin-dependent proteolysis of tissue factor pathway inhibitor in a mouse model of endotoxemia.
Lupu C; Herlea O; Tang H; Lijnen RH; Lupu F
J Thromb Haemost; 2013 Jan; 11(1):142-8. PubMed ID: 23106863
[TBL] [Abstract][Full Text] [Related]
60. Infections and endothelial cells.
Keller TT; Mairuhu AT; de Kruif MD; Klein SK; Gerdes VE; ten Cate H; Brandjes DP; Levi M; van Gorp EC
Cardiovasc Res; 2003 Oct; 60(1):40-8. PubMed ID: 14522405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
